Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06074497
Title A Phase 1, First-in-Human of KGX101 to Patients With Advanced or Metastatic Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Kangabio AUSTRALIA LTD PTY
Indications
Therapies
Age Groups: adult
Covered Countries AUS


No variant requirements are available.